MedPath

S.O.S. NALOXONE HYDROCHLORIDE INJECTION

S.O.S. NALOXONE HYDROCHLORIDE INJECTION

Approved
DIN Number

02453266

Drug Class

Human

Market Date

N/A

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02453266
AIG Number0108981001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB15 NALOXONE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous ,  Subcutaneous
AHFS Classification28:10.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NALOXONE HYDROCHLORIDEActive
Strength: 1 MG / ML
Monograph: NALOXONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.